Guest guest Posted February 18, 2004 Report Share Posted February 18, 2004 Dear All: I think it is important to bring to the attention some latest research from the Retrovirus conference. Efavirenz, when combined with other NRTI'ss is an excellent drug to control HIV infection. As for other combination there may be a need to stop HAART for any number of reasons- side effects, interactions...etc. There was paper which showed that once the efavirenz based combo is stopped efavirenz levels continue to be present at theraputic doses for as long as two weeks (especially so in people of african origin). How does this impact clinical practice? Research has shown that NNRTI mutation can develop even with very few doses of NNRTI [(some say just one dose is enough), (e.g as in NEVIRAPINE used for vertical tranmsission prevention). So, when a NNRTI based cocktail is stopped, levels of NNRTI (both efavirenz and nevirapine) are high enough to elicit the virus to mutate. Based on this there have been suggestions that when a NNRTI based combination has to be stopped for whatever reason, it may be advisable to continue the other two drugs in the cocktail. For eg AZT and Epivr [if they were part of the combination of AZT, EPIVIR and NNRI (efavirenz or combivir)] to be continued for up to 1-2 weeks after the NNRTI is stopped. By this, the risk of NNRTI staying alone in the blood for two weeks and thus exposing it to chance of developing resistance can be prevented. This is particularly important in the developing world where NNRTI's are the mainstay of HIV treatment. Vijayabhaskar Reddy Kandula AIDS Healthcare Foundation, N La Cienega Blvd, St 200 Beverly Hills CA 90211. Ph: 310 657 9353 ext 224 e-mail:<emailreddy@...> Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.